Holen Sie sich die Stockscreener-App
0.8101
4.79%
-0.0408
Handel nachbörslich:
.82
0.0099
+1.22%
Rani Therapeutics Holdings Inc Aktie (RANI) Neueste Nachrichten
Rani Therapeutics Holdings Inc - TradingKey
Rani Therapeutics Holdings Inc (RANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rani Therapeutics Holdings Inc (RANI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
RANI|Rani Therapeutics Holdings Inc|Price:0.851|Chg%:-0.039 - TradingKey
Rani Therapeutics Hldgs Market Sentiment - Benzinga España
TradingKey - TradingKey
Form 4 Rani Therapeutics Holdings Inc For: 24 July By Investing.com - Investing.com South Africa
Rani Therapeutics director Mir A Imran buys $24,839 in stock By Investing.com - Investing.com Nigeria
Rani Therapeutics director Mir A Imran buys $24,839 in stock - Investing.com
Rani Therapeutics Holdings Inc. (RANI) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Rani Therapeutics Holdings Inc (RANI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director IMRAN MIR A - Moomoo
Rani Therapeutics (RANI) insider Imran Mir A buys 36,000 shares - Stock Titan
Rani Therapeutics Holdings (NASDAQ:RANI) surges 29%, shrinking Nasdaq compliance deficit to 11% - TechStock²
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Form 4 Rani Therapeutics Holdings Inc For: 22 July By Investing.com - Investing.com South Africa
Rani Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Javadi Alireza - Moomoo
Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Form 4 Rani Therapeutics Holdings Inc For: 21 July By Investing.com - Investing.com Nigeria
Rani Therapeutics (RANI) CTO records stock sale and tax withholding - Stock Titan
Rani Therapeutics CEO Talat Imran buys $25,193 in stock - Investing.com
Rani Therapeutics CEO Talat Imran buys $25,193 in stock By Investing.com - Investing.com UK
Rani Therapeutics (RANI) CEO purchases 35,000 shares in open-market trade - Stock Titan
Rani Therapeutics (RANI) CEO logs RSU-related tax share sales - Stock Titan
Rani Therapeutics (RANI) grants 2M stock options to its CFO - Stock Titan
Rani Therapeutics’ New CFO Receives 2M-Share Stock Option - Stock Titan
ETFs Investing in Rani Therapeutics Holdings, Inc. Class A Stocks - TradingView
MOLN Stock Price and Chart — NASDAQ:MOLN - TradingView
Rani Therapeutics partners with PegBio on obesity drugs By Investing.com - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT) - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
CCORF Maintains Rani Therapeutics(RANI.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing - Sahm
RANI Stock Price, Quote & Chart - ChartMill
Rani Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Rani Therapeutics Tries To Turn Biologic Shots Into Pills - Finimize
Rani TherapeuticsPhase 1B Study Expected t - Moomoo
Rani Therapeutics reports positive Phase 1 data for oral obesity drug - Investing.com South Africa
Rani Therapeutics Reports Positive Initial Phase 1a Data for RT-114 in Obesity - marketscreener.com
Rani Therapeutics Reports Positive Phase 1a Data for Oral RT-114, Achieving Greater Than 150% Systemic Exposure Versus Matched Subcutaneous Dose - Quiver Quantitative
Rani Therapeutics Announces Positive Initial Phase 1a Data - GlobeNewswire
Rani Therapeutics Holdings (RANI) Surges 4.93%: Testing Resistance After Bouncing Off SupportPairs Trade - dars.gov.et
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), GE Healthcare Technologies Inc (GEHC) - The Globe and Mail
PegBio Partners Rani for Oral Metabolic Disease Drugs - AllSci
Rani collaborates with Pegbio on oral drug delivery in obesity - BioWorld News
Why Did Rani Therapeutics (NASDAQ:RANI) Announce New Collaboration? - Kalkine Media
PegBio Teams with Rani Therapeutics to Pursue Oral Metabolic Therapies - TipRanks
Rani Therapeutics, PegBio Collaborate on Oral Delivery of Obesity Drugs - Moomoo
Rani Therapeutics partners with PegBio on obesity drugs - Investing.com
Rani Therapeutics Announces Research and Development - GlobeNewswire
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):